We've got news for you.

Register on BusinessLIVE at no cost to receive newsletters, read exclusive articles & more.
Register now

State-backed vaccine manufacturer Biovac has clinched a deal with a consortium of development finance institutions to raise $150m (R2.3bn) to fund the expansion of its Cape Town-based facility, to produce up to 1-billion doses a year.

It bolsters SA’s plans to increase its domestic vaccine production capacity, and reduce the risk of standing at the back of the queue again in future health emergencies. ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now

Would you like to comment on this article?
Register (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.

Commenting is subject to our house rules.